Yizhou Dong PhD

Dr. Yizhou Dong is the Mount Sinai Endowed Professor in Nanomedicine at the Icahn School of Medicine at Mount Sinai. He received his B.S. in pharmaceutical sciences from Peking University Health Science Center and his M.S. in organic chemistry from Shanghai Institute of Organic Chemistry. In 2009, he received his Ph.D. degree in pharmaceutical sciences from the University of North Carolina at Chapel Hill (UNC-CH) under the supervision of Professor K.-H. Lee. From 2010 to 2014, he was a postdoctoral fellow in the laboratory of Professors Robert Langer and Daniel Anderson at Harvard Medical School and Massachusetts Institute of Technology. Dr. Dong joined the OSU College of Pharmacy as an Assistant Professor in 2014 and was promoted to Associate Professor in 2018.

His research focuses on the design and development of biotechnology platforms for the treatment of genetic disorders, infectious diseases, and cancers. Dr. Dong has authored over one hundred papers and patents. Several of his inventions have been licensed and are currently under development as drug candidates for clinical trials. He serves as a scientific advisory board member for Arbor Biotechnologies and Sirnagen Therapeutics. Dr. Dong is the recipient of multiple awards, such as the Maximizing Investigators’ Research Award from the National Institute of General Medical Sciences (NIGMS), the Ohio State Early Career Innovator of the Year, and the American Association of Pharmaceutical Scientists (AAPS) Emerging Leader Award. Dr. Dong is an elected fellow of the American Institute for Medical and Biological Engineering (AIMBE) and also an elected fellow of the National Academy of Inventors.